Cardiac Resynchronization Therapy Using Left-bundle-branch Area Pacing and Coronary Sinus Pacing
Xiang-Fei Feng,Rui Zhang,Yi-Chi Yu,Bo Liu,Ya-Qin Han,Qiu-Fen Lu,Yi-Gang Li
DOI: https://doi.org/10.21203/rs.3.rs-428239/v2
2021-01-01
Abstract:Abstract Background: Cardiac resynchronization therapy via biventricular pacing (BVP) is an established therapy for patients with heart failure. Recently, it has been shown that left bundle branch area pacing (LBBAP) is feasible and may also improve clinical outcomes. In this article, we describe a new technique (sequential LBBAP followed by coronary sinus pacing, designated LOT-CRT) and assess the feasibility of LOT-CRT.Methods: The database of all patients with adaptive CRT from single centre was reviewed retrospectively. The eligible patients were divided into two groups, LOT-CRT and BV-CRT. The LBBAP lead implanted using our methods. The QRS duration (QRSd) was measured at baseline and during LBBAP, BVP, and LOT-CRT.Results: The study enrolled 17 consecutive heart failure patients with LBBB. LBBAP failed in 1 patient, succeed in 8 patients, while CS leads were implanted successfully in all patients. At baseline, the two groups (8 cases in LOT-CRT group, 9 cases in BV-CRT group) were matched for QRSd and ischemic cardiomyopathy (ICM, 5 cases in LOT-CRT group, 4 cases in BV-CRT group). In LOT-CRT group, BVP resulted in significant reduction of the QRSd from 158.0 ± 13.0 ms at baseline to 132.0 ± 4.5 ms (P=0.019). Compared with BVP, unipolar LBBAP resulted in further reduction of the QRSd to 123.0 ± 5.7 ms (P < 0.01). However, LOT-CRT with adaptive algorithm resulted in a significantly greater reduction of the QRSd to 117.0 ± 6.7 ms (P < 0.01). In BV-CRT group, BVP resulted in significant reduction of the QRSd from 176.7 ±19.7 ms at baseline to 143.3 ±8.2 ms (P=0.011). However, compared with LOT-CRT, BVP has no any advantage in reducing QRSd (P >0.05). As compared to the baseline after 3 months of LBBAP, patients in LOT-CRT group showed significant improvement in LVEF and NT-proBNP levels (P < 0.01), while patients in BV-CRT group showed non-significant changes in these parameters (P >0.05).Conclusions: The study demonstrates that LOT-CRT is clinically feasible in patients with systolic HF and LBBB. LOT-CRT was associated with significant narrowing of the QRSd and improvement in LV function, especially in patients with ICM.